Assessment of performance measures for patients with the myelodysplastic syndrome (MDS) in the United States.

6002 Background: Although baseline bone marrow examination and assessment of iron stores before initiating an erythropoiesis-stimulating agent (ESA) are nationally endorsed performance measures for...